Delivery Order SPE2DR25D2005-SPE2DR26FE7U6
- Not listed
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $2,282.30 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply) on November 24, 2025, with an ultimate completion date of November 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count units) valued at $11,211.06. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of December 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was competed among all eligible vendors....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets in a quantity of 90 units, with a contract ceiling value of $4,609.72. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) under a firm fixed-price contract valued at $2,040.27. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation and represents a competitive award. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Valsartan-HCTZ 160-25 mg tablets in quantities of 90 units, with a contract ceiling value of $11,676.65. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Valsartan-HCTZ 320-12.5 mg tablets in a 90-count quantity, with a ceiling value of $2,955.68. This firm fixed-price delivery order, with an ultimate completion date of November 6, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency awarded a delivery order valued at $1,717.95 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCT 320-25 mg tablets in a 90-count package. This competitively awarded, non-set-aside contract is classified as a firm fixed-price delivery order with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $29,710.91 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-12.5 mg tablets in a quantity of 90 units. The contract was competitively awarded without set-aside designation under a firm fixed price arrangement, with an ultimate completion date of November 4, 2025. The award was issued on November 3, 2025, and the pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,397.13 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-12.5 mg tablets (90-count supply) on September 24, 2025, with completion scheduled for September 25, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7U6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTz 320-25 mg tablets (90-count) with a ceiling value of $4,853.07. This is a firm fixed price delivery order with an award date of December 1, 2025, and an ultimate completion date of December 2, 2025. The contract utilizes no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, with demonstrated capabilities across multiple therapeutic domains and price points, making it well-positioned to fulfill the Defense Logistics Agency's pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 11/30/25 |